As drug trials continue to combat Covid-19, DG of Council of Science and Industrial research has said that it is unfair to compare hydroxychloroquine & remdesivir.
Dr. Shekar C Mande said that even US has approved remdesivir only for critically ill patients and added that it's difficult to make a conclusion till the trial of the drugs is not complete.
Watch the video for all the details.